Chang et al. [23] classified IDH-1 mutation, 1p/19q codeletion, and MGMT promoter methylation status in malignant glioma using a convolutional neural network with overall accuracies of 94%, 92%, and 83%, respectively. This evidence concerns the gene MGMT and malignant glioma.